ContextPrescription drugs are instrumental to managing and preventing chronic disease.
Recent changes in US prescription drug cost sharing could affect access to them …

Background—As medication spending grows, Medicare Part D will need to adapt its
coverage policies according to emerging evidence from a variety of insurance policies. We …

BACKGROUND The use of antisecretory medication (H2 blockers and proton pump
inhibitors) is increasing rapidly, and constitutes 4-11% of the medical budget in the UK …

This paper describes and assesses pharmaceutical pricing and reimbursement policies in
Canada, considering them in the context of the broader policy and market environment in …

In the current economic environment, health care systems are constantly struggling to
contain rapidly rising costs. Drug costs are targeted by a wide variety of measures. Many …

Objective To evaluate the effects of patient copayment and coinsurance policies on
adherence to therapy with β-adrenergic blocking agents (β-blockers) and on the rate of …

Therapeutic reference pricing is one of the potential cost containment methods for
pharmaceuticals. The most critical question of reference pricing is how to select reference …

Multiple interacting factors influence the uptake and diffusion of medicines which are critical
to improving health. However, there is a gap in our knowledge on how regulatory policies …

Abstract Rationale In Belgium, several policies regulating reimbursement of acid
suppressant drugs and evidence‐based recommendations for clinical practice were issued …

Background. Michigan Medicaid outpatient prescription drug program implemented the
following four policies to address rising expenditures considered" out of control":(1) February …